Spotlight on the new ACC/AHA lipid and JNC8 hypertension guidelines, EGFR inhibitors vs chemotherapy for NSCLC, and more.
- Author
- American Medical Association
- Published
- Tue 08 Apr 2014
- Episode Link
- http://dx.doi.org/10.1001/jama.2013.279430
Editor's Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the April 09, 2014 issue
